Bioventus (BVS) Inventory Average (2021 - 2026)

Bioventus' Inventory Average history runs 6 years deep, the most recent figure standing at $82.7 million for Q1 2026.

• Quarterly Inventory Average fell 11.31% year-over-year to $82.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $82.7 million (down 11.31% YoY) and the FY2025 annual result came in at $87.4 million, down 4.95% from the prior year.
• Inventory Average was $82.7 million for Q1 2026 at Bioventus, down from $89.3 million in the prior quarter.
• Across five years, Inventory Average topped out at $96.9 million in Q3 2023 and bottomed at $63.2 million in Q2 2022.
• A 5-year average of $86.9 million and a median of $91.3 million in 2024 frame the typical range for Inventory Average.
• Annual changes were most pronounced in 2022 — Inventory Average soared 106.89% — and 2026, when it decreased 11.31%.
• Bioventus' Inventory Average stood at $80.9 million in 2022, then grew by 16.81% to $94.4 million in 2023, then fell by 3.38% to $91.3 million in 2024, then slipped by 2.19% to $89.3 million in 2025, then declined by 7.33% to $82.7 million in 2026.
• Business Quant data shows BVS's Inventory Average at $82.7 million in Q1 2026, $89.3 million in Q4 2025, and $96.4 million in Q3 2025.